Skip to main navigation Skip to search Skip to main content

Clinical Outcomes in Neovascular Age-related Macular Degeneration with Aflibercept 8 mg in the Phase II CANDELA Study

Jordana G. Fein, Priya S. Vakharia, A. Paul Chous, Rutvi Desai, Fabiana Q. Silva, Kimberly Reed, Alyson J. Berliner, Robert Vitti, Charles C. Wykoff

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)915-918
Number of pages4
JournalOphthalmology Retina
Volume9
Issue number9
DOIs
StatePublished - Sep 2025

Keywords

  • Aflibercept
  • High dose
  • Neovascular age-related macular degeneration
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Ophthalmology

Cite this